Cargando…

Statins alone or polypill for primary prevention of cardiovascular diseases

Detalles Bibliográficos
Autores principales:	Hasani-Ranjbar, Shirin, Ejtahed, Hanieh-Sadat
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2016
Materias:	Commentary
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5142144/ https://www.ncbi.nlm.nih.gov/pubmed/27981041 http://dx.doi.org/10.1186/s40200-016-0280-4

Ejemplares similares

The most important challenges ahead of microbiome pattern in the post era of the COVID-19 pandemic
por: Ejtahed, Hanieh-Sadat, et al.
Publicado: (2020)

Polypill for Population-Level Primary Cardiovascular Prevention in Underserved Populations—A Social Epidemiology Counterargument
por: Cainzos-Achirica, Miguel, et al.
Publicado: (2020)

The polypill in the primary prevention of cardiovascular disease: cost-effectiveness in the Dutch population
por: van Gils, Paul F, et al.
Publicado: (2011)

Multifactorial Prevention of Cardiovascular Disease in Patients with Hypertension: the Cardiovascular Polypill
por: Lafeber, M., et al.
Publicado: (2016)

The feasibility of polypill for cardiovascular disease prevention in Asian Population
por: Sukonthasarn, Apichard, et al.
Publicado: (2020)

Polypills for Primary Prevention of Cardiovascular Disease: A Systematic Review and Meta-Analysis
por: Kandil, Omneya A., et al.
Publicado: (2022)

Strengths and Limitations of Using the Polypill in Cardiovascular Prevention
por: Roy, Ambuj, et al.
Publicado: (2017)

The effect of “moderately restricted carbohydrate” diet on gut microbiota composition and metabolic parameters in women with metabolic syndrome: a study protocol for a randomized controlled trial
por: Mousavi, Seyed Mohammad, et al.
Publicado: (2022)

Gut microbiota-derived metabolites in obesity: a systematic review
por: EJTAHED, Hanieh-Sadat, et al.
Publicado: (2020)

Gut microbiota modulation as a possible mediating mechanism for fasting-induced alleviation of metabolic complications: a systematic review
por: Angoorani, Pooneh, et al.
Publicado: (2021)

Ethical challenges in conducting and the clinical application of human microbiome research
por: Ejtahed, Hanieh Sadat, et al.
Publicado: (2023)

SLC34A3 Intronic Deletion in an Iranian Kindred with Hereditary Hypophosphatemic Rickets with Hypercalciuria
por: Hasani-Ranjbar, Shirin, et al.
Publicado: (2018)

The effects of probiotics, prebiotics, and synbiotics on polycystic ovarian syndrome: an overview of systematic reviews
por: Angoorani, Pooneh, et al.
Publicado: (2023)

Process evaluation of the impact and acceptability of a polypill for prevention of cardiovascular disease
por: Wood, Frances, et al.
Publicado: (2015)

A Polypill for primary prevention of cardiovascular disease: A feasibility study of the World Health Organization
por: Soliman, Elsayed Z, et al.
Publicado: (2011)

Benefits of the Polypill on Medication Adherence in the Primary and Secondary Prevention of Cardiovascular Disease: A Systematic Review
por: Lopez-Lopez, Jose P, et al.
Publicado: (2023)

Medicinal herbs: Potential polypills in cardiovascular diseases
por: Noroozi, Samaneh, et al.
Publicado: (2021)

Risk‐benefit analysis of use of statins for primary prevention of cardiovascular disease in subjects without diabetes
por: Chan, Juliana CN
Publicado: (2013)

Probiotics as a New Regulator for Bone Health: A Systematic Review and Meta-Analysis
por: Malmir, Hanieh, et al.
Publicado: (2021)

Worldwide trends in scientific publications on association of gut microbiota with obesity
por: Ejtahed, Hanieh-Sadat, et al.
Publicado: (2019)

Prevalence of metabolic syndrome and health-related quality of life in war-related bilateral lower limb amputees
por: Ejtahed, Hanieh-Sadat, et al.
Publicado: (2017)

Effect of garlic extract on weight loss and gut microbiota composition in obese women: A double-blind randomized controlled trial
por: Ettehad-Marvasti, Fateme, et al.
Publicado: (2022)

Practical Decision Algorithms for the Use of the Cardiovascular Polypill in Secondary Prevention in Europe
por: Grigorian-Shamagian, Lilian, et al.
Publicado: (2021)

The Effectiveness of Polypill for the Prevention of Cardiovascular Disease: A Meta-Analysis of Randomized Controlled Trials
por: Virk, Ghazala S, et al.
Publicado: (2023)

Cost–benefit analysis of the polypill in the primary prevention of myocardial infarction and stroke
por: Wald, Nicholas J., et al.
Publicado: (2016)

Probiotics as a Complementary Therapy for Management of Obesity: A Systematic Review
por: Shirvani-Rad, Salman, et al.
Publicado: (2021)

Polypill for atherosclerotic cardiovascular disease prevention in Haiti: Eligibility estimates in a low-income country
por: Yan, Lily D., et al.
Publicado: (2022)

Could patents interfere with the development of a cardiovascular polypill?
por: Beall, Reed F., et al.
Publicado: (2016)

Redefining the polypill: pros and cons in cardiovascular precision medicine
por: Birla, Siddharth, et al.
Publicado: (2023)

Discriminatory ability of visceral adiposity index as an indicator for modeling cardio-metabolic risk factors in pediatric population: the CASPIAN-V study
por: Ejtahed, Hanieh-Sadat, et al.
Publicado: (2019)

Cost-effectiveness of fixed-dose combination pill (Polypill) in primary and secondary prevention of cardiovascular disease: A systematic literature review
por: Jahangiri, Reza, et al.
Publicado: (2022)

Polypill—Friend or Foe?
por: Rishi, Rakesh Kumar
Publicado: (2011)

Correction: Cost-effectiveness of fixed-dose combination pill (Polypill) in primary and secondary prevention of cardiovascular disease: A systematic literature review
por: Jahangiri, Reza, et al.
Publicado: (2023)

The polypill approach – An innovative strategy to improve cardiovascular health in Europe
por: Fuster, Valentín, et al.
Publicado: (2017)

Effect of the Polypill on Adherence and Prevention of Cardiovascular Diseases in Patients With or at High Risk of Cardiovascular Diseases: A Meta-Analysis of Randomized Controlled Trials
por: Memon, Rahat A, et al.
Publicado: (2023)

The Polypill: From Promise to Pragmatism
por: Huffman, Mark D.
Publicado: (2015)

Polypill revisited – Unity in diversity
por: Dan, Gheorghe-Andrei, et al.
Publicado: (2020)

Cost-effectiveness analysis of use of a polypill versus usual care or best practice for primary prevention in people at high risk of cardiovascular disease
por: Jowett, Sue, et al.
Publicado: (2017)

Statins for primary cardiovascular prevention in the elderly
por: Pedro-Botet, Juan, et al.
Publicado: (2015)

Aspirin for primary prevention of cardiovascular disease in diabetes
por: Xing, Ying, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_184pa6ehcl2na11eh8ih3f2hsg